MedTrace Logo

Sub-study of the Essen Study Centre for the ENTAiER Trial

NCT04532073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-12-21

No results posted yet for this study

Summary

The present study is a sub-study of the ENTAiER study. The ENTAiER study is a multicenter, randomized, controlled study to evaluate the efficacy and safety of eurythmy therapy and Tai Chi in comparison to standard care in chronically ill older patients with an increased risk of falling.

In addition to the main questions of the ENTAiER study, three additional questions are being investigated at the Hospital Essen-Steele: Proteome and telomere analyses as well as qualitative parameters are recorded and examined. The aim is to compare the changes in proteomes, telomeres and qualitative factors under eurythmy therapy, Tai Chi and standard care in chronically ill older patients with an increased risk of falling.

Conditions

  • Elderly Patients
  • Chronically Ill
  • Increased Risk of Falling

Interventions

OTHER

Eurythmy Therapy

A mindfulness-oriented movement therapy

OTHER

Tai Chi

A martial art developed in China, which in recent times is often regarded as a system of movement theory or gymnastics

OTHER

Standard Care

Treatment process that a clinician should follow for a certain type of patient

Sponsors & Collaborators

  • Software AG Stiftung

    collaborator UNKNOWN

  • Universität Freiburg

    collaborator UNKNOWN

  • Universität Duisburg-Essen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-27
Primary Completion
2022-12-07
Completion
2022-12-07

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04532073 on ClinicalTrials.gov